Research progress of intra-aortic balloon counterpulsation in the treatment of acute myocardial infarction with cardiogenic shock: A review

Mengxian Li,Liqun Hu,Lei Li

DOI: https://doi.org/10.1097/md.0000000000036500

IF: 1.6

2024-02-23

Medicine

Abstract:Cardiogenic shock is a state of low cardiac output, resulting in life-threatening terminal organ hypoperfusion and hypoxia. Acute myocardial infarction (AMI) complicated with left ventricular dysfunction is still the most common cause of cardiogenic shock. Although the survival rate has been improved in recent years, the morbidity and mortality of patients are still very high, cardiogenic shock is the main cause of death during hospitalization in patients with AMI. [ 1 ] The global registration study shows that the overall incidence of AMI complicated with cardiogenic shock is 4%~12% and the 30-day mortality rate is as high as 40%~45%. [ 2 ] Before routine application of early revascularization, the in-hospital mortality rate of cardiogenic shock is as high as 80%. [ 3 ] Intra-aortic balloon counterpulsation (IABP) is the most widely used mechanical circulatory support device in cardiogenic shock, [ 4 ] which provides short-term hemodynamic and clinical improvement for most patients. [ 5 ] Although patients have received IABP treatment, the mortality rate is still high, according to the admission parameters, patients with a higher risk of death should be further treated with other mechanical circulatory support devices. [ 6 ]

medicine, general & internal